Screener
Sotera Health SHC Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 55%-0.6pp | 55.3%+0.1pp | 55.5%+0.7pp | 56%+0.8pp | 55.5%+0.3pp | |
| Net margin | 13.4%+11.3pp | 9.9%+7.7pp | 6.7%+2.7pp | 4.8%-1.5pp | 2.1%-1.5pp | |
| Returns | ||||||
| Return on equity | 27.8%+22.6pp | 22.7%+16.8pp | 15.4%+5.0pp | 10.9%-5.8pp | 5.1%-4.4pp | |
| Return on invested capital | 2.9%+1.1pp | 1.3%-2.5pp | -0.2%-6.2pp | 0.9%-5.8pp | 1.8%-4.4pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Liquidity | ||||||
| Current ratio | 2.8×+0.3× | 2.8×+0.4× | 2.5×-0.3× | 2.4×-0.5× | 2.5×-0.5× | |
| Leverage | ||||||
| Debt-to-equity | 3.4×-1.2× | 3.6×-2.0× | 3.8×-2.1× | 4.1×-0.9× | 4.6×-1.0× | |
| Net debt / EBITDA | 7.8×-0.3× | 10.7×+5.0× | 15×+10.5× | 10.5×+6.2× | 8.1×+3.6× | |
| Per Share | ||||||
| Book value per share | $2.31+29.1% | $2.16+48.2% | $2.12+48.9% | $1.92+16.6% | $1.79+20.4% | |
| Valuation | ||||||
| Market capitalization | $5.13B+71.8% | $4.08B+23.4% | $5.01B+29.3% | $4.47B-5.4% | $3.19B-4.7% | |
| Price / earnings | 31.4×-92.9× | 34.6×-98.6× | 64.3×-23.0× | 80.6×+13.8× | 132.8×+49.4× | |
| Price / sales | 4.2×+1.6× | 3.4×+0.4× | 4.3×+0.8× | 3.9×-0.3× | 2.8×-0.2× | |
| Price / book | 8.1×+2.0× | 6.6×-1.4× | 8.3×-1.3× | 8.1×-1.9× | 6.2×-1.7× | |
| EV / EBITDA | 29.7×+9.0× | 33.1×+18.0× | 54×+41.1× | 34.3×+20.1× | 20.9×+9.3× |
FAQ
- What are Sotera Health's profit margins?
- Sotera Health (SHC) runs a 55.0% gross margin and a 27.0% operating margin, with a 13.4% net margin.
- Where do Sotera Health's ratios come from?
- Every ratio is computed from Sotera Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
